Onset of protective immunity in chicks after vaccination with a recombinant herpesvirus of turkeys vaccine expressing Newcastle disease virus fusion and hemagglutinin-neuraminidase antigens.
The onset of protective immunity from lethal Newcastle disease virus (NDV) challenge of chicks was determined after vaccination with a recombinant herpes virus of turkeys (HVT) expressing the fusion and hemagglutinin-neuraminidase proteins of NDV. One-day-old specific-pathogen-free chicks devoid of maternal antibodies to NDV were vaccinated with 130 to 3300 plaque forming units of HVT (depending on the trial) and then challenged at 4, 7, 10, and 14 days postvaccination (DPV) with a neurotropic velogenic strain of NDV (GB Texas). The recombinant vaccine afforded 0%, 35-75%, 85%, and 94-100% protection when the vaccinated birds were challenged at 4, 7, 10, and 14 DPV, respectively. In all trials, challenge caused 100% mortality in unvaccinated control chicks. Newcastle disease virus was reisolated from the lung, liver, spleen, and brain of birds dying in all trials regardless of vaccine dosage or time of challenge, except when challenge occurred at 14 DPV.
Heckert
R A
RA
Agriculture and Agri-Food Canada, Animal Diseases Research Institute, Nepean, Ontario, Canada.
Riva
J
J
Cook
S
S
McMillen
J
J
Schwartz
R D
RD
D000818:Animals; D000941:Antigens / Q000032:analysis* / Q000276:immunology / Q000378:metabolism; D001921:Brain / Q000821:virology; D002645:Chickens / Q000276:immunology*; D015707:HN Protein / Q000032:analysis / Q000235:genetics / Q000276:immunology*; D006564:Herpesviridae / Q000276:immunology* / Q000302:isolation & purification / Q000378:metabolism; D006566:Herpesviridae Infections / Q000276:immunology / Q000517:prevention & control / Q000662:veterinary; D007110:Immunity, Active / Q000276:immunology*; D008099:Liver / Q000821:virology; D008168:Lung / Q000821:virology; D009521:Newcastle Disease / Q000276:immunology / Q000517:prevention & control; D009522:Newcastle disease virus / Q000276:immunology* / Q000302:isolation & purification / Q000378:metabolism; D011201:Poultry Diseases / Q000276:immunology / Q000517:prevention & control; D013154:Spleen / Q000821:virology; D014422:Turkeys / Q000276:immunology*; D014614:Vaccines, Synthetic / Q000032:analysis / Q000276:immunology / Q000627:therapeutic use*; D014760:Viral Fusion Proteins / Q000032:analysis / Q000235:genetics / Q000276:immunology*; D014765:Viral Vaccines / Q000032:analysis* / Q000276:immunology / Q000627:therapeutic use*
D000941:Antigens; D015707:HN Protein; D014614:Vaccines, Synthetic; D014760:Viral Fusion Proteins; D014765:Viral Vaccines